Cost-effectiveness of lenalidomide in the treatment of patients with transfusion-dependent myelodysplastic syndromes (MDS) in the United States.

被引：0
|
作者：
Goss, TF
Szende, A
Brueckner, J
Wang, M
Schaefer, C
List, AF
机构：
[1] Covance Mkt Access Serv, Gaithersburg, MD USA
[2] Covance Mkt Access Serv, Leeds, W Yorkshire, England
[3] Celgene Corp, Pharmacoecon, Summit, NJ USA
[4] Univ S Florida, Moffit Canc Ctr & Res Inst, Tampa, FL USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1338
引用
收藏
页码：388A / 389A
页数：2
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS OF DEFERASIROX VERSUS DEFEROXAMINE IN TRANSFUSION-DEPENDENT THALASSAEMIA PATIENTS IN HONG KONG-AN INITIAL ANALYSIS
    Lee, K. K.
    Chow, D. P.
    Lau, H.
    Pramanik, A.
    Delea, T. E.
    Sofrygin, O.
    Shi, W.
    VALUE IN HEALTH, 2010, 13 (07) : A565 - A565
  • [42] Cost-effectiveness in Canada of azacitidine for the treatment of higher-risk myelodysplastic syndromes
    Levy, A. R.
    Zou, D.
    Risebrough, N.
    Buckstein, R.
    Kim, T.
    Brereton, N.
    CURRENT ONCOLOGY, 2014, 21 (01) : E29 - E40
  • [43] Cost-effectiveness of HIV testing and treatment in the United States
    Walensky, Rochelle P.
    Freedberg, Kenneth A.
    Weinstein, Milton C.
    Paltiel, A. David
    CLINICAL INFECTIOUS DISEASES, 2007, 45 : S248 - S254
  • [44] Optimising management of deferasirox therapy for patients with transfusion-dependent thalassaemia and lower-risk myelodysplastic syndromes
    Kattamis, Antonis
    Aydinok, Yesim
    Taher, Ali
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 101 (03) : 272 - 282
  • [45] Iron-Chelating Therapies in a Transfusion-Dependent Thalassaemia Population in ThailandA Cost-Effectiveness Study
    Nantasit Luangasanatip
    Nathorn Chaiyakunapruk
    Nilawan Upakdee
    Peerapon Wong
    Clinical Drug Investigation, 2011, 31 : 493 - 505
  • [46] Iron-Chelating Therapies in a Transfusion-Dependent Thalassaemia Population in Thailand A Cost-Effectiveness Study
    Luangasanatip, Nantasit
    Chaiyakunapruk, Nathorn
    Upakdee, Nilawan
    Wong, Peerapon
    CLINICAL DRUG INVESTIGATION, 2011, 31 (07) : 493 - 505
  • [47] Cost-effectiveness of haematopoietic stem cell transplantation for transfusion-dependent thalassaemia in comparison with conventional therapy
    Ho, WL
    Lin, KH
    Chern, JPS
    Lin, DT
    Jou, ST
    BONE MARROW TRANSPLANTATION, 2005, 35 : S187 - S187
  • [48] COMPARATIVE COST-EFFECTIVENESS ANALYSES OF IRON CHELATING THERAPIES IN TRANSFUSION-DEPENDENT THALASSAEMIA POPULATION IN THAILAND
    Luangasanatip, N.
    Chaiyakunapruk, N.
    Upakdee, N.
    Wong, P.
    VALUE IN HEALTH, 2010, 13 (07) : A565 - A565
  • [49] Cost-effectiveness of Nivolumab in Patients With NSCLC in the United States
    Chaudhary, Mohammad A.
    Lubinga, Solomon J.
    Smare, Caitlin
    Hertel, Nadine
    Penrod, John R.
    AMERICAN JOURNAL OF MANAGED CARE, 2021, 27 (08): : E254 - +
  • [50] Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes
    Lucijanic, Marko
    Lovrinov, Miran
    Skelin, Marko
    ANNALS OF INTERNAL MEDICINE, 2020, 173 (07) : 595 - 595
12345